Response to Joob and Wiwanitkit re: “Genetic Polymorphisms of Tumor Necrosis Factor Alpha and Susceptibility to Dengue Virus Infection in a Mexican Population”
Restricted accessLetterFirst published online November, 2017
Response to Joob and Wiwanitkit re: “Genetic Polymorphisms of Tumor Necrosis Factor Alpha and Susceptibility to Dengue Virus Infection in a Mexican Population”
Diario Oficial de la Federación. NORMA oficial Mexicana NOM-032-SSA2-2014, Para la vigilancia epidemiológica, promoción, prevención y control de las enfermedades transmitidas por vectores. DOF: 16/04/2015. www.dof.gob.mx/nota_detalle.php?codigo=5389045&fecha=16/04/2015 [Spanish] (accessed July24, 2017).
2.
JoobB, and WiwanitkitV.Re: “Genetic Polymorphisms of Tumor Necrosis Factor Alpha and Susceptiblity to Dengue Virus Infection in a Mexican Population” by Sánchez-Leyva et al. Viral Immunol, 2017; 30:678.
3.
RosenbergerKD, LumL, AlexanderN, et al.Vascular leakage in dengue—clinical spectrum and influence of parenteral fluid therapy. Trop Med Int Health, 2016; 21:445–453.
4.
Sánchez-LeyvaM, Sánchez-ZazuetaJG, Osuna-RamosJF, et al.Genetic polymorphisms of tumor necrosis factor alpha and susceptibility to dengue virus infection in a Mexican population. Viral Immunol, 2017; 30:615–621.
5.
World Health Organization (WHO). Dengue Guidelines for Diagnosis, Treatment, Prevention, and Control. 3rd ed. Geneva, Switzerland: WHO, 2009.
